(
A) RNAP inhibition experiment using rifampicin. Normalized 3C-seq contact maps for strains with two
parSopt sites spaced by ~300 kb (mock treatment control ‘rif-’, top panel) (rif treatment ‘rif+’, bottom panel). (
B) Schemes depicting possible scenario for collision avoidance and collision resolution: exclusive usage of a single
parS site by SMC complexes as a consequence of temporary inactivation of remaining
parS sites. (
C) Read count distribution for chromatin immunoprecipitation coupled to deep sequencing (ChIP-seq) using α-ScpB serum for a strain with eight
parS sites deleted, single
parSopt at −9 kb, two
parS sites at −304 kb and −9 kb, −9 kb and +328 kb or −304 kb and +328 kb. Represented as in
Figure 2—figure supplement 1B. (
D) Read count distribution for chromatin immunoprecipitation coupled to deep sequencing (ChIP-seq) using α-ParB serum as in (
C).